Title : Recombinant human complement C5a receptor antagonist reduces infarct size after surgical revascularization.

Pub. Date : 2000 Aug

PMID : 10917953






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CONCLUSIONS: We conclude that the recombinant human C5a receptor antagonist CGS 32359 inhibits surgical ischemia-reperfusion injury after coronary occlusion. cysteinylglycine complement C5a receptor 1 Homo sapiens